CHAT Pilot Trial: Study Protocol for H1N1 Treatment
Author Information
Author(s): Karen EA Burns, Clarence Chant, Orla Smith, Brian Cuthbertson, Robert Fowler, Deborah J Cook, Peter Kruger, Steve Webb, Jamal Alhashemi, Guillermo Dominguez-Cherit, Carlos Zala, Gordon D Rubenfeld, John C Marshall
Primary Institution: University of Toronto
Hypothesis
Can rosuvastatin improve outcomes in critically ill patients with H1N1 infection?
Conclusion
The CHAT pilot trial aims to assess the feasibility of conducting a larger trial on the effects of rosuvastatin in critically ill patients with H1N1.
Supporting Evidence
- Statins may help reduce inflammation in severe infections.
- Previous studies suggest statins could lower mortality in patients with influenza.
- The trial aims to evaluate the feasibility of conducting research during a pandemic.
Takeaway
This study is trying to see if a common cholesterol medicine can help people very sick with a type of flu called H1N1.
Methodology
A multi-national, pilot randomized controlled trial comparing rosuvastatin to placebo in critically ill patients with suspected H1N1.
Potential Biases
Potential bias due to the use of open-label treatments and the challenges of conducting research in a pandemic setting.
Limitations
The study's feasibility is challenged by the need for rapid implementation during a pandemic and the complexities of obtaining consent.
Participant Demographics
Critically ill adults aged 16 and older with suspected or confirmed H1N1 infection.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website